There are other candidate B-lymphocyte stimulators, such as anti-S protein antibodies developed after exposure to SARS-CoV-2, which stimulate the production of anti-idiotype antibodies after the COVID-19 vaccination [158]. This evidence concerns the gene PROS1 and COVID-19.